SCHEMBL26674988

SCHEMBL26674988

CC(=NO)c1cc(C(F)(F)F)nn1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ GRN P28799 1/20 0.41
▸ SORT1 Q99523 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ KCNT1 Q5JUK3 6/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12474102 0.83 KDM4E (0.41) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL13064210 0.79 KDM4E (0.51) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL20763649 0.79 KDM4E (0.43) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL17920 0.75 GRN (0.71) KDM4EGRNSORT1ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8932269 0.74 GRN (0.69) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL20745023 0.74 KDM4E (0.42) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL951323 0.74 KDM4E (0.50) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL17732 0.74 KDM4E (0.50) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL20763628 0.72 KDM4E (0.45) KDM4EGRNSORT1ALDH1A1CYP3A4
SCHEMBL30305711 0.72 KDM4E (0.49) KDM4EGRNSORT1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357152-A1 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII BASF SE (DE) 2023-11-09 — — US disclosed
CN-116056576-A Use of strobilurin type compounds for combating phytopathogenic fungi containing F129L amino acid substitutions conferring tolerance to Qo inhibitor VIII in mitochondrial cytochrome b proteins 巴斯夫欧洲公司 2023-05-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357152-A1 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII COX5B, COX6B1, SQOR KDM4E 2949/4885GRN 2581/4885SORT1 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback